September 1, 1965Annals of SurgeryOpen Access

Intraluminal Chemotherapy Adjuvant (HN2 or 5-FU) to Operation for Cancer of the Colon and Rectum

View Full Paper

Ask AI

Bookmark

Authors

LRLouis M. RousselotNational Institutes of Health DCDonald R. ColeSaint Vincent's Catholic Medical Center JSJohn SlatteryEinstein Healthcare Network

Abstract

Rousselot, Louis M. M.D., F.A.C.S.; Cole, Donald R. M.D., F.A.C.S.; Slattery, John M.D., F.A.C.S.; Grossi, Carlo E. M.D., F.A.C.S.; Gonzalez, Eduardo M. M.D. Author Information

Discussion

Member takes

Cite This Study

Rousselot et al. (1965) studied this question.

synapsesocial.com/papers/6a87143548ef9afcd2a25d3e https://doi.org/10.1097/00000658-196509000-00010

View Full Paper

Ask AI

Bookmark

Abstract

Rousselot, Louis M. M.D., F.A.C.S.; Cole, Donald R. M.D., F.A.C.S.; Slattery, John M.D., F.A.C.S.; Grossi, Carlo E. M.D., F.A.C.S.; Gonzalez, Eduardo M. M.D. Author Information

Intraluminal Chemotherapy Adjuvant (HN2 or 5-FU) to Operation for Cancer of the Colon and Rectum

Abstract

Discussion

Member takes

Cite This Study

Intraluminal Chemotherapy Adjuvant (HN2 or 5-FU) to Operation for Cancer of the Colon and Rectum

Abstract

Discussion

Member takes

Cite This Study

Also Consider

Also Consider